Abstract :

Amyloid plaques are one of the key reasons in progression of Alzheimer’s disease (AD) being one of the leading causes of dementia. Recent studies have shown evidence to the levels of cholesterol playing an important role in the formation of amyloid plaque. This work aims to analyse the effect of cholesterol levels in increasing amyloid plaques accumulation in the brain, how it can influence breakdown of amyloid precursor protein (APP) and how specific foods and diet can affect it formation of amyloid plaques. The research findings indicate that high levels cholesterol directly influences enzyme activity and clearance mechanisms in the brain. Low-Density Lipoprotein (LDL), commonly known as ‘bad’ cholesterol, transports cholesterol to various tissues and has been found to influence the risk of Alzheimer’s disease across different age groups. Managing cholesterol levels before the age of sixty-five may help reduce the likelihood of developing Alzheimer’s.

---

Keywords :

Alzheimer’s disease, Amyloid beta (Aβ), Amyloid plaques, Amyloid Precursor Protein (APP), Cholesterol, Low-Density lipoprotein (LDL).

---

References :

1. Rushworth JV, Hooper NM. Lipid Rafts: Linking Alzheimer’s Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes. Int J Alzheimers Dis. 2010 Dec 27; 2011:603052. doi: 10.4061/2011/603052. PMID: 21234417; PMCID: PMC3014710.
2. Tsatsanis A, Wong BX, Gunn AP, Ayton S, Bush AI, Devos D, Duce JA. Amyloidogenic processing of Alzheimer’s disease β-amyloid precursor protein induces cellular iron retention. Mol Psychiatry. 2020 Sep;25(9):1958-1966. doi: 10.1038/s41380-020-0762-0. Epub 2020 May 22. PMID: 32444869.
3. Ghribi O, Larsen B, Schrag M, Herman MM. High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol. 2006 Aug;200(2):460-7. doi: 10.1016/j.expneurol.2006.03.019. Epub 2006 May 11. PMID: 16696972.
4. Marquer C, Devauges V, Cossec JC, Liot G, Lécart S, Saudou F, Duyckaerts C, Lévêque-Fort S, Potier MC. Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB 5.J. 2011 Apr;25(4):1295-305. doi: 10.1096/fj.10-168633. Epub 2011 Jan 21. Erratum in: FASEB J. 2012 Jan;26(1):468. PMID: 21257714.
5. Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789. PMID: 33302541; PMCID: PMC7764106.
6. Rudajev V, Novotny J. Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease. Front Mol Neurosci. 2022 Aug 25; 15:937056. doi: 10.3389/fnmol.2022.937056. PMID: 36090253; PMCID: PMC9453481.
7. O’Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci. 2011; 34:185-204. doi: 10.1146/annurev-neuro-061010-113613. PMID: 21456963; PMCID: PMC3174086.
8. Hampel, H., Hardy, J., Blennow, K. et al.The Amyloid-β Pathway in Alzheimer’s Disease. Mol Psychiatry 26, 5481–5503 (2021). https://doi.org/10.1038/s41380-021-01249-0 [9
9. Zhou R, Chen LL, Yang H, Li L, Liu J, Chen L, Hong WJ, Wang CG, Ma JJ, Huang J, Zhou XF, Liu D, Zhou HD. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer’s Disease. Curr Alzheimer Res. 2021;18(5):428-442. doi: 10.2174/1567205018666210906092940. PMID: 34488598.
10. Craig M, Yarrarapu SNS, Dimri M. Biochemistry, Cholesterol. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513326/
11. Lee Y, Siddiqui WJ. Cholesterol Levels. [Updated 2023 Jul 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542294/
12. Li, Z., Shue, F., Zhao, N. et al.APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease. Mol Neurodegeneration 15, 63 (2020). https://doi.org/10.1186/s13024-020-00413-4
13. Sven Grösgen, Marcus O.W. Grimm, Petra Frieß, Tobias Hartmann,”Role of amyloid beta in lipid homeostasis, Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids”, Volume 1801, Issue 8,2010, Pages 966-974, ISSN 1388-1981,
14. Lee SI, Jeong W, Lim H, Cho S, Lee H, Jang Y, Cho J, Bae S, Lin YT, Tsai LH, Moon DW, Seo J. APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation. Stem Cell Reports. 2021 Sep 14;16(9):2128-2137. doi: 10.1016/j.stemcr.2021.07.017. Epub 2021 Aug 26. PMID: 34450034; PMCID: PMC8452535.
15. Qian L, Chai AB, Gelissen IC, Brown AJ.,” Balancing cholesterol in the brain: from synthesis to disposal”, Explor Neuroprot Ther”,2022; 2:1-27. https://doi.org/10.37349/ent.2022.00015
16. Valenza, M., Marullo, M., Di Paolo, E. et al.Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington’s disease. Cell Death Differ 22, 690–702 (2015). https://doi.org/10.1038/cdd.2014.162
17. Iwagami M, Qizilbash N, Gregson J, Douglas I, Johnson M, Pearce N, Evans S, Pocock S. Blood cholesterol and risk of dementia in more than 1·8 million people over two decades: a retrospective cohort study. Lancet Healthy Longev. 2021 Aug;2(8):e498-e506. doi: 10.1016/S2666-7568(21)00150-1. Epub 2021 Jul 23. PMID: 36097999.
18. Sáiz-Vazquez O, Puente-Martínez A, Ubillos-Landa S, Pacheco-Bonrostro J, Santabárbara J. Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis. Brain Sci. 2020 Jun 18;10(6):386. doi: 10.3390/brainsci10060386. PMID: 32570800; PMCID: PMC7349210.
19. Kanekiyo T, Bu G. The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease. Front Aging Neurosci. 2014 May 20; 6:93. doi: 10.3389/fnagi.2014.00093. PMID: 24904407; PMCID: PMC4033011.
20. Kline A. Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer’s disease. Alzheimers Res Ther. 2012 Aug 27;4(4):32. doi: 10.1186/alzrt135. PMID: 22929359; PMCID: PMC3506946.
21. Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 2008 Dec;118(12):4002-13. doi: 10.1172/JCI36663. Epub 2008 Nov 13. PMID: 19033669; PMCID: PMC2582453.
22. Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM. ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci U S A. 2013 May 7;110(19):E1807-16. doi: 10.1073/pnas.1220484110. Epub 2013 Apr 25. PMID: 23620513; PMCID: PMC3651443.
23. Melinda Wenner Moyer MIND Diet: Best Foods to Eat to Keep Your Brain Young eatingwell.com
24. Orywal, K.; Socha, K.; Iwaniuk, P.; Kaczyński, P.; Farhan, J.A.; Zoń, W.; Łozowicka, B.; Perkowski, M.; Mroczko, B. Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases.  J. Mol. Sci.2025, 26, 1333. https://doi.org/10.3390/ijms26031333
25. Balashova OA, Visina O, Borodinsky LN. Folate action in nervous system development and disease. Dev Neurobiol. 2018 Apr;78(4):391-402. doi: 10.1002/dneu.22579. Epub 2018 Feb 6. PMID: 29380544; PMCID: PMC5867258.
26. Devore EE, Kang JH, Breteler MM, Grodstein F. Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol. 2012 Jul;72(1):135-43. doi: 10.1002/ana.23594. Epub 2012 Apr 26. PMID: 22535616; PMCID: PMC3582325.
27. Minocha T, Birla H, Obaid AA, Rai V, Sushma P, Shivamallu C, Moustafa M, Al-Shehri M, Al-Emam A, Tikhonova MA, Yadav SK, Poeggeler B, Singh D, Singh SK. Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer’s Disease. Oxid Med Cell Longev. 2022 Aug 28; 2022:6038996. doi: 10.1155/2022/6038996. PMID: 36071869; PMCID: PMC9441372.
28. Al-Furaydi, A. and Al-Sowayan, N. (2023) Protective Effect of an Anthocyanin on Alzheimer’s Disease. Advances in Bioscience and Biotechnology, 14, 505-513. doi: 4236/abb.2023.1412035.
29. Devore EE, Kang JH, Breteler MM, Grodstein F. Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol. 2012 Jul;72(1):135-143. doi: 10.1002/ana.23594. Epub 2012 Apr 26. PMID: 22535616; PMCID: PMC3582325.
30. Yamakawa MY, Uchino K, Watanabe Y, Adachi T, Nakanishi M, Ichino H, Hongo K, Mizobata T, Kobayashi S, Nakashima K, Kawata Y. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer’s disease. Nutr Neurosci. 2016;19(1):32-42. doi: 10.1179/1476830515Y.0000000042. Epub 2015 Aug 25. PMID: 26304685.
31. Kelsey,” Ogletree 6 nuts and seeds that can give your brain a boost”, AARP.org
32. Kelly Kennedy,” almonds, walnuts, or pistachios: which is the healthiest nut?” Everydayhealth.com
33. Lana Barhum 11 nuts and seeds that are are high in magnesium verywellhealth.com
34. Lattimer JM, Haub MD. Effects of dietary fiber and its components on metabolic health. Nutrients. 2010 Dec;2(12):1266-89. doi: 10.3390/nu2121266. Epub 2010 Dec 15. PMID: 22254008; PMCID: PMC3257631.
35. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999 Jan;69(1):30-42. doi: 10.1093/ajcn/69.1.30. PMID: 9925120.
36. Bao J, Liang Z, Gong X, Yu J, Xiao Y, Liu W, Wang X, Wang JZ, Shu X. High Fat Diet Mediates Amyloid-β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice. J Alzheimers Dis. 2022;85(2):863-876. doi: 10.3233/JAD-215299. PMID: 34864680.
37. Shen H, He L, Price RL, Fernandez ML. Dietary soluble fiber lowers plasma LDL cholesterol concentrations by altering lipoprotein metabolism in female guinea pigs. J Nutr. 1998 Sep;128(9):1434-41. doi: 10.1093/jn/128.9.1434. PMID: 9732302.
38. Ruan Y, Tang J, Guo X, Li K, Li D. Dietary Fat Intake and Risk of Alzheimer’s Disease and Dementia: A Meta-Analysis of Cohort Studies. Curr Alzheimer Res. 2018;15(9):869-876. doi: 10.2174/1567205015666180427142350. PMID: 29701155.
39. Islam MA, Amin MN, Siddiqui SA, Hossain MP, Sultana F, Kabir MR. Trans fatty acids and lipid profile: A serious risk factor to cardiovascular disease, cancer and diabetes. Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1643-1647. doi: 10.1016/j.dsx.2019.03.033. Epub 2019 Mar 16. PMID: 31336535.
40. trans fat is double trouble for health mayo clinic
41. Morris MC, Evans DA, Bienias JL, et al. Dietary Fats and the Risk of Incident Alzheimer Disease. Arch Neurol.2003;60(2):194–200. doi:10.1001/archneur.60.2.194
42. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7. doi: 10.1073/pnas.0230450100. Epub 2003 Mar 12. PMID: 12634421; PMCID: PMC153065.
43. Hernández-Rodríguez M, Clemente CF, Macías-Pérez ME, Rodríguez-Fonseca RA, Vázquez MIN, Martínez J, Ruvalcaba RM, Rosas MM, Jiménez EM. Contribution of hyperglycemia-induced changes in microglia to Alzheimer’s disease pathology. Pharmacol Rep. 2022 Oct;74(5):832-846. doi: 10.1007/s43440-022-00405-9. Epub 2022 Aug 31. PMID: 36042131.
44. Jacobo-Albavera L, Domínguez-Pérez M, Medina-Leyte DJ, González-Garrido A, Villarreal-Molina T. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease. Int J Mol Sci. 2021 Feb 5;22(4):1593. doi: 10.3390/ijms22041593. PMID: 33562440; PMCID: PMC7915494.